FMR LLC reports beneficial ownership of 6,790,364 shares of CLIMB BIO INC common stock, representing 11.9% of the class as of 06/30/2026. The filing (Schedule 13G) states FMR LLC holds sole dispositive power over these shares and identifies Abigail P. Johnson as having dispositive power. The report lists the issuer CUSIP 28658R106 and provides FMR's principal office in Boston.
Positive
None.
Negative
None.
Insights
FMR LLC holds a meaningful passive stake in CLIMB BIO (11.9%).
FMR LLC reports beneficial ownership of 6,790,364 shares with sole dispositive power as of 06/30/2026. The Schedule 13G classification indicates passive investment rather than active control.
Key dependencies include whether holdings change in subsequent filings and any disclosures in Exhibit 99; future filings will show adjustments to position or classification.
Filing clarifies voting and dispositive authorities tied to FMR LLC and Abigail P. Johnson.
The report shows sole voting power: 6,790,089 and sole dispositive power: 6,790,364 as stated on the cover information. Signatures reference a power of attorney effective April 13, 2026.
Investors tracking ownership concentration should note the 11.9% stake and review subsequent disclosures for any reclassification or Schedule 13D triggers.
Key Figures
Beneficial ownership:6,790,364 sharesPercent of class:11.9%Sole voting power:6,790,089 shares+4 more
7 metrics
Beneficial ownership6,790,364 sharesAmount beneficially owned as reported in Item 4 (as of 06/30/2026)
Percent of class11.9%Percent of common stock reported in Item 4 (as of 06/30/2026)
Sole voting power6,790,089 sharesSole voting power reported on cover information
Sole dispositive power6,790,364 sharesSole dispositive power reported on cover information
CUSIP28658R106Issuer CUSIP listed in Item 2(e)
Ownership as of06/30/2026Reporting date tied to ownership figures
Filing signature date07/07/2026Date signatures were executed on the Schedule 13G
Key Terms
Schedule 13G, Beneficially owned, Sole Dispositive Power, CUSIP
4 terms
Schedule 13Gregulatory
"Item 1. (a) Name of issuer: CLIMB BIO INC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Dispositive Powerregulatory
"cover: Sole Dispositive Power 6,790,364.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
CUSIPother
"Item 2. (e) CUSIP Number(s): 28658R106"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
FAQ
What stake does FMR LLC disclose in CLIMB BIO (CLYM)?
FMR LLC discloses beneficial ownership of 6,790,364 shares, equal to 11.9% of the class as of 06/30/2026. The Schedule 13G indicates a passive reporting classification and lists sole dispositive power over these shares.
Who is named as having dispositive power over the CLYM shares?
The filing names FMR LLC with sole dispositive power and lists Abigail P. Johnson as having dispositive power for the same 6,790,364 shares. The cover shows voting and dispositive power figures reported by the filer.
Which CUSIP and issuer address appear on the Schedule 13G for CLYM?
The filing lists CUSIP 28658R106 for CLIMB BIO INC and the issuer address as 20 STREET, SUITE 145, WELLESLEY HILLS, MA 02481. These details appear in the Item 1 issuer identification section.
What is the filing date and who signed the Schedule 13G for CLYM?
The Schedule 13G shows an effective ownership date of 06/30/2026 and is signed on 07/07/2026 by Richard Bourgelas, authorized under a power of attorney on behalf of FMR LLC and Abigail P. Johnson.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
CLIMB BIO INC
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
28658R106
(CUSIP Number)
06/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
28658R106
1
Names of Reporting Persons
FMR LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
6,790,089.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
6,790,364.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,790,364.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.9 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
28658R106
1
Names of Reporting Persons
Abigail P. Johnson
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
6,790,364.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,790,364.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
11.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
CLIMB BIO INC
(b)
Address of issuer's principal executive offices:
20 WILLIAM STREET,SUITE 145,WELLESLEY HILLS,MA,USA,02481
Item 2.
(a)
Name of person filing:
FMR LLC
(b)
Address or principal business office or, if none, residence:
245 Summer Street, Boston, Massachusetts 02210
(c)
Citizenship:
Not applicable
(d)
Title of class of securities:
COMMON STOCK
(e)
CUSIP Number(s):
28658R106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
6790364.00
(b)
Percent of class:
11.9 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Please see the responses to Items 5 and 6 on the cover page.
(ii) Shared power to vote or to direct the vote:
0.00
(iii) Sole power to dispose or to direct the disposition of:
6790364.00
(iv) Shared power to dispose or to direct the disposition of:
0.00
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CLIMB BIO INC. No one other person's interest in the COMMON STOCK of CLIMB BIO INC is more than five percent of the total outstanding COMMON STOCK.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See attached Exhibit 99.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
FMR LLC
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:
07/07/2026
Abigail P. Johnson
Signature:
Richard Bourgelas
Name/Title:
Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:
07/07/2026
Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
